Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Pre CPhI Special

How green was my Valium? Not very, despite industry claims

Green chemistry yet to attract drug industry

Making active pharmaceutical ingredients (API) is a dirty business and you’d have to be pretty green to believe claims drug industry 'demand' will create a $100bn market for environmentally-friendly production methods by 2020.

Related news

News in brief

The world is getting larger, at least it is in terms of the pharmaceutical industry, according to execs who cite security concerns when shipping to new markets as the top logistics worry.

A laser diffraction imaging tool could be used by quality controllers to help measure particle size in a suspension according to Malvern Instruments.

Boehringer Ingelheim is investing more than €100m ($126m) at its Dortmund, Germany site to expand production capacity for its Respimat inhaler, which is the third time in the past four years that the company has made a capacity-expanding investment at the site.

Indian generic manufacturer Marck Biosciences has received a warning letter from the US FDA for failing to pay its annual facility fees for the past two years, which for foreign fixed-dose formulation facilities in 2014 was $235,152 .

The acquisition of Shasun Pharmaceuticals will add API production and contracting services to Strides Arcolab, and according to Shasun’s CEO no jobs will be lost.

Hampered by manufacturing issues, Impax Laboratories has decided to settle a lawsuit over allegations related to the issues in order “to eliminate the uncertainty, distraction, burden and expense of further litigation,” the company said in a SEC filing .

Global Industry News

Novotech moves into China with new Shanghai office after requests from US and EU customers from

Australia’s largest clinical CRO Novotech has expanded its services into China with a new office in Shanghai.


MAb production driving continuous fermentation, says GEA from

Development of continuous fermentation has been driven by the increased production of monoclonal antibodies says GEA, with Asia-Pacific the new growth driver for such technologies.

Medidata hit by $4.8m wire fraud, but says customer clinical trial data is safe from

Fraudsters who hoodwinked Medidata Solutions into transferring $4.8m to an "overseas" account this month did not access customer data says the clinical trial IT firm.

LabCorp to acquire NMR-focused, personalized diagnostic company LipoScience for $85m from

CRO LabCorp has entered a definitive agreement to acquire LipoScience for $5.25 per share, or about $85.3m (€67.2m).

PPD increases stake in small molecule discovery company X-Chem citing Big Pharma relationships from

CRO PPD has exercised its option to acquire the remaining minority ownership interest of X-Chem for an undisclosed sum. X-Chem will continue to operate as a small molecule discovery company with its entire existing staff and management team. 

Some positive milestone news for Evotec: Bayer collaboration enters animal testing from

Evotec has announced positive milestone news this week, revealing that efforts to develop an endometriosis drug with Bayer have moved into preclinical testing.

ex-RPS CIO drops wrongful dismissal lawsuit and allegations the CRO unlawfully stored applicant data from

An ex RPS employee who claimed he was sacked after discovering the CRO was unlawfully storing potential employees’ personal data has settled his lawsuit and withdrawn allegations of wrongdoing.

Waiting on the US: Rapid biosimilar uptake worldwide stalling, report finds from

Chief among the potential drivers for the world’s biosimilar market is establishing a market in the US, which continues to stall, according to a new report.


Galen plans to sell “green whistle” pain drug in UK and Ireland

Galen plans to sell “green whistle” inhalable pain drug in UK and Ireland

Almac’s subsidiary Galen has licensed UK sales and marketing rights to an emergency pain drug nicknamed the...

Trial transparency: NICE stands firm on data

Trial transparency: NICE stands firm on data

The UK’s NICE says it will go over drug companies’ heads and get clinical trial data from...

Mannkind looks to Sanofi for secondary supply of inhalable insulin API

Mannkind looks to Sanofi for secondary supply of inhalable insulin API

Mannkind says Sanofi could become a second API supplier for its recently approved inhalable insulin drug Afrezza...

Drug prices will continue to vary accross Africa says analyst

Drug prices will continue to vary accross Africa says analyst

High importation costs and country-to-country differences in national healthcare systems mean drugmakers will continue to vary the...

Hyperion ends drug candidate truials after discovering fake data

$20m Andromeda strains Hyperion as fake data ends diabetes drug development

Hyperion says it is “shocked and disheartened” after discovering Phase III trial data for a type 1...

ISPE offers preview to drug shortages prevention plan

ISPE offers preview to drug shortages prevention plan

The International Society for Pharmaceutical Engineering (ISPE) last week offered up a preview to its plan to...

Key Industry Events


Access all events listing

Our events, Events from partners...